PDF(Pubmed)
Abstract：
We herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.
摘要：
我们在此报告一例长期冠状病毒病2019（COVID-19）伴滤泡性淋巴瘤患者的间质性肺改变病例，该患者接受利妥昔单抗和苯达莫司汀治疗，经皮质类固醇和免疫抑制剂联合治疗后康复。目前尚无针对COVID-19后长期肺炎的治疗策略，这可能会危及免疫功能低下患者的生命。因此，需要进一步调查。
